491 related articles for article (PubMed ID: 19837282)
1. Advances in the development of next-generation anthrax vaccines.
Friedlander AM; Little SF
Vaccine; 2009 Nov; 27 Suppl 4():D28-32. PubMed ID: 19837282
[TBL] [Abstract][Full Text] [Related]
2. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
[TBL] [Abstract][Full Text] [Related]
3. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for improved anthrax vaccines.
Brey RN
Adv Drug Deliv Rev; 2005 Jun; 57(9):1266-92. PubMed ID: 15935874
[TBL] [Abstract][Full Text] [Related]
5. [Progress on the vaccine for anthrax].
Zhan DW; Wang P; Wang LC; Zhang ZS
Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):149-52. PubMed ID: 15847185
[TBL] [Abstract][Full Text] [Related]
6. BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge.
Köhler SM; Baillie LW; Beyer W
Vaccine; 2015 Jun; 33(24):2771-7. PubMed ID: 25917676
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of an anthrax DNA vaccine with electroporation.
Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R
Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850
[TBL] [Abstract][Full Text] [Related]
8. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques.
Livingston BD; Little SF; Luxembourg A; Ellefsen B; Hannaman D
Vaccine; 2010 Jan; 28(4):1056-61. PubMed ID: 19896452
[TBL] [Abstract][Full Text] [Related]
9. Anthrax vaccines.
Friedlander AM; Welkos SL; Ivins BE
Curr Top Microbiol Immunol; 2002; 271():33-60. PubMed ID: 12224523
[TBL] [Abstract][Full Text] [Related]
10. Past, imminent and future human medical countermeasures for anthrax.
Baillie LW
J Appl Microbiol; 2006 Sep; 101(3):594-606. PubMed ID: 16907809
[TBL] [Abstract][Full Text] [Related]
11. Development of anthrax DNA vaccines.
Ferrari ME; Hermanson G; Rolland A
Curr Opin Mol Ther; 2004 Oct; 6(5):506-12. PubMed ID: 15537052
[TBL] [Abstract][Full Text] [Related]
12. Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.
Bouzianas DG
Expert Rev Anti Infect Ther; 2007 Aug; 5(4):665-84. PubMed ID: 17678429
[TBL] [Abstract][Full Text] [Related]
13. [Vaccination strategies for anthrax prevention].
Beyer W
Berl Munch Tierarztl Wochenschr; 2004; 117(11-12):508-24. PubMed ID: 15584433
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.
Hahn UK; Boehm R; Beyer W
Vaccine; 2006 May; 24(21):4569-71. PubMed ID: 16157424
[TBL] [Abstract][Full Text] [Related]
15. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
Wang HC; An HJ; Yu YZ; Xu Q
Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364
[TBL] [Abstract][Full Text] [Related]
17. Anthrax capsule vaccine protects against experimental infection.
Chabot DJ; Scorpio A; Tobery SA; Little SF; Norris SL; Friedlander AM
Vaccine; 2004 Nov; 23(1):43-7. PubMed ID: 15519706
[TBL] [Abstract][Full Text] [Related]
18. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
Sloat BR; Shaker DS; Le UM; Cui Z
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
[TBL] [Abstract][Full Text] [Related]
19. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
Sloat BR; Cui Z
Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
[TBL] [Abstract][Full Text] [Related]
20. [Selected research problems of anthrax vaccine development].
Zakowska D; Kocik J; Bartoszcze M
Przegl Epidemiol; 2009; 63(4):505-12. PubMed ID: 20120948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
